These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
583 related articles for article (PubMed ID: 10809299)
1. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Maxvold NJ; Smoyer WE; Custer JR; Bunchman TE Crit Care Med; 2000 Apr; 28(4):1161-5. PubMed ID: 10809299 [TBL] [Abstract][Full Text] [Related]
2. Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Kellum JA; Johnson JP; Kramer D; Palevsky P; Brady JJ; Pinsky MR Crit Care Med; 1998 Dec; 26(12):1995-2000. PubMed ID: 9875910 [TBL] [Abstract][Full Text] [Related]
3. Comparison of solute clearance in three modes of continuous renal replacement therapy. Parakininkas D; Greenbaum LA Pediatr Crit Care Med; 2004 May; 5(3):269-74. PubMed ID: 15115566 [TBL] [Abstract][Full Text] [Related]
4. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy]. Gong D; Ji D; Xie H; Xu B; Liu Y; Li L Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577 [TBL] [Abstract][Full Text] [Related]
5. Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole. Muhl E; Martens T; Iven H; Rob P; Bruch HP Eur J Clin Pharmacol; 2000 Dec; 56(9-10):671-8. PubMed ID: 11214774 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients. Guenter SG; Iven H; Boos C; Bruch HP; Muhl E Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556 [TBL] [Abstract][Full Text] [Related]
7. Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis. Davies SP; Reaveley DA; Brown EA; Kox WJ Crit Care Med; 1991 Dec; 19(12):1510-5. PubMed ID: 1959370 [TBL] [Abstract][Full Text] [Related]
8. Optimal Mode of clearance in critically ill patients with Acute Kidney Injury (OMAKI)--a pilot randomized controlled trial of hemofiltration versus hemodialysis: a Canadian Critical Care Trials Group project. Wald R; Friedrich JO; Bagshaw SM; Burns KE; Garg AX; Hladunewich MA; House AA; Lapinsky S; Klein D; Pannu NI; Pope K; Richardson RM; Thorpe K; Adhikari NK Crit Care; 2012 Oct; 16(5):R205. PubMed ID: 23095370 [TBL] [Abstract][Full Text] [Related]
9. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Saudan P; Niederberger M; De Seigneux S; Romand J; Pugin J; Perneger T; Martin PY Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022 [TBL] [Abstract][Full Text] [Related]
10. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis. Joy MS; Matzke GR; Frye RF; Palevsky PM Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848 [TBL] [Abstract][Full Text] [Related]
11. Prospective randomized trial to assess caloric and protein needs of critically Ill, anuric, ventilated patients requiring continuous renal replacement therapy. Scheinkestel CD; Kar L; Marshall K; Bailey M; Davies A; Nyulasi I; Tuxen DV Nutrition; 2003; 19(11-12):909-16. PubMed ID: 14624937 [TBL] [Abstract][Full Text] [Related]
12. Nitrogen and amino acid balance during total parenteral nutrition and continuous arteriovenous hemofiltration in critically ill anuric children. Kuttnig M; Zobel G; Ring E; Grubbauer HM; Kurz R Child Nephrol Urol; 1991; 11(2):74-8. PubMed ID: 1756524 [TBL] [Abstract][Full Text] [Related]
13. Cost analysis of two modalities of continuous renal replacement therapy. Duriseti P; Idrees N; Aldairem A; Jaber BL; Balakrishnan VS Hemodial Int; 2021 Apr; 25(2):173-179. PubMed ID: 33103356 [TBL] [Abstract][Full Text] [Related]
14. CVVHD results in longer filter life than pre-filter CVVH: Results of a quasi-randomized clinical trial. Mann L; Ten Eyck P; Wu C; Story M; Jenigiri S; Patel J; Honkanen I; O'Connor K; Tener J; Sambharia M; Fraer M; Nourredine L; Somers D; Nizar J; Antes L; Kuppachi S; Swee M; Kuo E; Huang CL; Jalal DI; Griffin BR PLoS One; 2023; 18(1):e0278550. PubMed ID: 36630406 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Bellomo R; Tipping P; Boyce N Ren Fail; 1995 Jul; 17(4):457-66. PubMed ID: 7569116 [TBL] [Abstract][Full Text] [Related]
16. CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations. Lorenzin A; Garzotto F; Alghisi A; Neri M; Galeano D; Aresu S; Pani A; Vidal E; Ricci Z; Murer L; Goldstein SL; Ronco C Pediatr Nephrol; 2016 Oct; 31(10):1659-65. PubMed ID: 27139897 [TBL] [Abstract][Full Text] [Related]
17. Management of acute renal failure in the critically ill with continuous venovenous hemodiafiltration. Bellomo R; Parkin G; Love J; Boyce N Ren Fail; 1992; 14(2):183-6. PubMed ID: 1636025 [TBL] [Abstract][Full Text] [Related]
18. Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal replacement therapy. Leblanc M; Garred LJ; Cardinal J; Pichette V; Nolin L; Ouimet D; Geadah D Am J Kidney Dis; 1998 Sep; 32(3):444-53. PubMed ID: 9740161 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration. Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806 [TBL] [Abstract][Full Text] [Related]